Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Implications of genome-wide association studies in cancer therapeutics.

British journal of clinical pharmacology - 1 Sept 2013

Patel Jai N, McLeod Howard L, Innocenti Federico

Abstract excerpt

Genome wide association studies (GWAS) provide an agnostic approach to identifying potential genetic variants associated with disease susceptibility, prognosis of survival and/or predictive of drug response. Although these techniques are costly and interpretation of study results is challenging, they do allow for a more unbiased interrogation of the entire genome, resulting in the discovery of novel genes and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Clinical Trials as Topic
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genome-Wide Association Study

Share to Germ-Line Mutation

Share to Neoplasms

Share to Predictive Value of Tests

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 23701381
DOI: 10.1111/bcp.12166
PMCID: PMC3769665

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Implications of genome-wide association studies in cancer therapeutics.PMID 23701381Read ↗

Genome-wide association study: a useful tool to identify common genetic variants associated with drug toxicity and efficacy in cancer pharmacogenomics.Semantic proximity Read ↗

Cancer Genetics and Implications for Clinical Management.Semantic proximity Read ↗

Genome-wide association studies of cancer: principles and potential utility.Semantic proximity Read ↗

Pharmacogenetics and pharmacogenomics of anticancer agents.Semantic proximity Read ↗

Approaches to the discovery of pharmacogenomic markers in oncology: 2000-2010-2020.Semantic proximity Read ↗

Role of genomics in identifying new targets for cancer therapy.Semantic proximity Read ↗

Use of pharmacogenetics for predicting cancer prognosis and treatment exposure, response and toxicity.Semantic proximity Read ↗

The use of genomic information to optimize cancer chemotherapy.Semantic proximity Read ↗

Identifying genetic variants that contribute to chemotherapy-induced cytotoxicity.Semantic proximity Read ↗

Cancer Pharmacogenomics: Early Promise, But Concerted Effort NeededSemantic proximity Read ↗

Pharmacogenetics in the cancer clinic: from candidate gene studies to next-generation sequencing.Semantic proximity Read ↗

Cancer pharmacogenetics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.